Stock Comparison
ABT vs GEHC
Abbott Laboratories and GE HealthCare Technologies Inc. side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$32.80B
P/E (TTM)
35.7
16.7
Forward P/E
20.0
14.7
Price/Sales
4.1
1.5
Price/Book
3.7
3.0
EV/EBITDA
18.6
11.2
Dividend Yield
1.66%
0.14%
Profitability
Net Margin
13.91%
7.54%
Operating Margin
18.17%
12.46%
Return on Equity
10.60%
19.40%
Return on Assets
5.33%
5.13%
Growth (YoY)
Revenue Growth
13.00%
5.80%
Earnings Growth
-47.50%
16.80%
Price & Risk
Beta
0.6
0.8
52-Week High
$134.48
$88.08
52-Week Low
$82.56
$59.49
Analyst Target
$118.42
$82.50
Compare ABT and GEHC your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.